Perrigo Bags FDA Final Approval For Generic Version Of Loprox Shampoo

Loprox (Ciclopirox Shampoo, 1%) is an antifungal indicated for the treatment of seborrheic dermatitis of the scalp in adults. According to Wolters Kluwer data, estimated annual brand sales for the product during the last twelve months were $26m.

Joseph Papa, CEO and chairman of Perrigo, said: “This approval is another example of Perrigo’s commitment to expand our portfolio and bring new products to market. It further demonstrates our strategy to deliver quality affordable healthcare for generic prescriptions and over the counter products.”

Perrigo develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. Perrigo’s primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico and the United Kingdom.